Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...
A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...
A look at the M&A and stock market pictures for full-year 2024—and the potential strategic implications for pharma and ...
Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) had soared by 15.8% as of 12:06 p.m. ET on Friday. Instead, the stock's ...
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...
In comparison, Massachusetts-based biotech companies received $7.89 billion in venture capital ... to provide some derisking.” Sign up for our BioFlash, TechFlash and Real Estate newsletters — all ...
With over 5 million concussions occurring annually in the U.S. alone, there is a significant unmet need for effective ...
The European Commission (EC) announced on January 29, 2025, that it launched a Biotech and Biomanufacturing Hub to support ...
New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...
A biotechnology company, however, must translate research ... And if these are not in place, there are often clear warning signs of this lack (see “Warning signs”). And it is here that we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback